| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1006179722 |
| P356 | DOI | 10.1007/S11154-014-9296-6 |
| P698 | PubMed publication ID | 25326656 |
| P50 | author | Ying Liu | Q80326311 |
| P2093 | author name string | André Marette | |
| Gary Sweeney | |||
| P2860 | cites work | Therapeutic perspectives for adiponectin: an update | Q38033213 |
| Myokines in myogenesis and health | Q38054913 | ||
| Adiponectin receptor as a key player in healthy longevity and obesity-related diseases | Q38076906 | ||
| The role of adiponectin signaling in metabolic syndrome and cancer | Q38135763 | ||
| Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance | Q38165106 | ||
| Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin. | Q38177917 | ||
| Adiponectin receptors: a review of their structure, function and how they work | Q38177918 | ||
| Adiponectin action in skeletal muscle | Q38177921 | ||
| Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity | Q38341759 | ||
| Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. | Q39720264 | ||
| PKC-theta knockout mice are protected from fat-induced insulin resistance | Q39989111 | ||
| Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. | Q40216912 | ||
| Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase | Q40227253 | ||
| Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts | Q40343968 | ||
| Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. | Q40477131 | ||
| Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy | Q40713483 | ||
| Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats | Q42170113 | ||
| Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis | Q42370007 | ||
| Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss | Q42494822 | ||
| Skeletal muscle inflammation is not responsible for the rapid impairment in adiponectin response with high-fat feeding in rats | Q43016757 | ||
| Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation | Q43264212 | ||
| Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle | Q43759228 | ||
| Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients | Q44883810 | ||
| Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction | Q44953893 | ||
| Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide | Q45078360 | ||
| Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats | Q46202689 | ||
| Globular adiponectin stimulates glucose transport in type 2 diabetic muscle | Q46491807 | ||
| Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects | Q47274454 | ||
| Opposing effects of adiponectin receptors 1 and 2 on energy metabolism | Q48259094 | ||
| Exercise training reverses adiponectin resistance in skeletal muscle of patients with chronic heart failure. | Q51026336 | ||
| Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. | Q55043111 | ||
| Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions | Q57249776 | ||
| Fat-1 mice convert n-6 to n-3 fatty acids | Q59062098 | ||
| Exercise restores insulin, but not adiponectin, response in skeletal muscle of high-fat fed rodents | Q87424729 | ||
| Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models | Q21135583 | ||
| Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q24304889 | ||
| Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 | ||
| APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function | Q24318702 | ||
| Road to exercise mimetics: targeting nuclear receptors in skeletal muscle | Q26825855 | ||
| Adiponectin, driver or passenger on the road to insulin sensitivity? | Q26827971 | ||
| Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance | Q28166649 | ||
| Resolution of inflammation: the beginning programs the end | Q29615695 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. | Q31030116 | ||
| Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells | Q33553662 | ||
| Pathogenesis of insulin resistance in skeletal muscle | Q33812448 | ||
| Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice | Q34118282 | ||
| Adiponectin signaling in the liver | Q34125349 | ||
| Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes | Q34315956 | ||
| Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice | Q34355211 | ||
| A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity | Q34381237 | ||
| Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice | Q34527073 | ||
| Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat | Q36179560 | ||
| Year in diabetes 2012: The diabetes tsunami | Q36442431 | ||
| Exercise training performed simultaneously to a high-fat diet reduces the degree of insulin resistance and improves adipoR1-2/APPL1 protein levels in mice | Q36517416 | ||
| Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis. | Q36635301 | ||
| Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation | Q36867543 | ||
| Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise | Q36939096 | ||
| Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise | Q36983863 | ||
| Role of adiponectin in human skeletal muscle bioenergetics | Q37163429 | ||
| Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies | Q37440055 | ||
| Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination | Q37760269 | ||
| Old and new generation lipid mediators in acute inflammation and resolution | Q37775277 | ||
| Adiponectin receptor binding proteins – recent advances in elucidating adiponectin signalling pathways | Q37793609 | ||
| P433 | issue | 4 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| glycobiology | Q899224 | ||
| P304 | page(s) | 299-305 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Reviews in Endocrine and Metabolic Disorders | Q15766899 |
| P1476 | title | Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome | |
| P478 | volume | 15 |
| Q38746239 | 8-Prenylnaringenin promotes recovery from immobilization-induced disuse muscle atrophy through activation of the Akt phosphorylation pathway in mice |
| Q52844332 | Abdominal fat distribution differently affects muscle strength of the upper and lower extremities in women. |
| Q53507648 | Acute exposure of primary rat soleus muscle to zilpaterol HCl (β2 adrenergic agonist), TNFα, or IL-6 in culture increases glucose oxidation rates independent of the impact on insulin signaling or glucose uptake. |
| Q39156608 | Circulating adipocyte-derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass |
| Q57031183 | Effect of dietary polyunsaturated fatty acid and antioxidant supplementation on the transcriptional level of genes involved in lipid and energy metabolism in swine |
| Q47644899 | OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. |
| Q96304996 | PFKFB3, a key glucose metabolic enzyme regulated by pathogen recognition receptor TLR4 in liver cells |
| Q50870803 | Reduced skeletal muscle secreted frizzled-related protein 3 is associated with inflammation and insulin resistance. |
| Q64280978 | Tumor protein 53-induced nuclear protein 1 deficiency alters mouse gastrocnemius muscle function and bioenergetics in vivo |
Search more.